BridgeBio Pharma Statistics
NASDAQ: BBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
76.03-2.15 (-2.75%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BridgeBio Pharma by the numbers
BridgeBio Pharma has a market capitalization of $14.81 billion based on 194.80M shares outstanding. With trailing EPS of $-3.03, BridgeBio Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% above its 50-day average and 4.5% above its 200-day average.
Average daily trading volume is 2.67M shares, or about $202.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BBIO valuation vs. peer median
| Metric | BBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.81B | $12.64B | +17% |
| Avg. volume | 2.67M | 1.97M | +35% |
Peer median across 8 companies: JAZZ, ASND, ELAN, RDY, BMRN, ALNY, TGTX, SYRE.
Valuation
- Market cap
- $14.81B
- Price / sales (latest FY)
- 29.50
- EPS (TTM)
- $-3.03
- Shares outstanding
- 194.80M
Price and trading
- Previous close
- 78.18
- Open
- 77.85
- Day range
- 75.46 – 78.22
- 52-week range
- 62.50 – 93.42
- 52-week change
- +11.63%
- Beta
- —
- Volume
- 1.48M
- Average volume
- 2.67M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 14.81B
- Forward Pe
- -278.15
- Eps
- -3.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 93.42
- Week52 Low
- 62.50
- Avg Volume
- 2.67M
- Shares Outstanding
- 194.80M
- Ma50
- 70.30
- Ma200
- 72.76
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -18.61%
- Pct From52w Low
- 21.65%